Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates – Intellia Therapeutics
- Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates Intellia Therapeutics
- Intellia Gears Up to Report Q3 Earnings: What’s in the Cards? Zacks Investment Research
- NTLA FY2027 EPS Reduced by Brookline Capital Management MarketBeat
- Intellia (NASDAQ: NTLA) completes HAELO Phase 3 enrollment; topline mid-2026 Stock Titan
- Intellia Therapeutics (NTLA) Expected to Announce Quarterly Earnings on Thursday MarketBeat